BSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.
Cohance Lifesciences Ltd: key numbers
- Share price
- ₹480.00
- Market cap
- ₹18,365 Cr
- Revenue (annual)
- ₹2,269 Cr
- Net profit (annual)
- ₹179.2 Cr
- P/E (TTM)
- 172.9×Sector 46.1×
- Promoter holding
- 57.48%-0.01% QoQ
- FII holding
- 7.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cohance Lifesciences Ltd
All →Cohance Lifesciences Other Announcement
Cohance Lifesciences Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b), disclosing promoter and public shareholding data as of September 30, 2026.
Cohance Lifesciences Regulatory Approval
Cohance Lifesciences received Central Government approval for the appointment of Mr. Umang Vohra as Chairman and Group CEO.
Cohance Lifesciences Employee Stock Options
Cohance Lifesciences Ltd. approved the grant of 2,60,194 stock options under ESOP 2026 and 6,14,594 stock options under ESOP 2023 to eligible employees.
Cohance Lifesciences Management Change
Cohance Lifesciences appointed Mr. Abhimanyu Ojha as the new Chief Financial Officer and Key Managerial Personnel, effective October 12, 2026.
Cohance Lifesciences Other Announcement
Cohance Lifesciences received a voluntary ESG Rating of Crisil ESG 61 (Strong) from Crisil ESG Ratings. No capital or business event is involved.
Cohance Lifesciences Business Update
Cohance Lifesciences completed a USFDA inspection at its Jaggaiahpet API facility, receiving a Form 483 with five observations. The company has initiated corrective and preventive actions.
Other board meeting date announcements
All →HMT Board Meeting Date
HMT Ltd will hold a board meeting on 6 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The notice is advance intimation only.
Svarnim Trade Udyog Board Meeting Date
Svarnim Trade Udyog will hold a board meeting on 3 November 2026 to consider unaudited quarterly and half-year results. No amounts are stated.
Intrasoft Technologies Board Meeting Date
Intrasoft Technologies will hold a board meeting on 06-Nov-2026 to consider unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. Trading window remains closed until 48 hours after the meeting.
Ruparel Food Products Board Meeting Date
Ruparel Food Products will hold a board meeting on 02-Nov-2026 to consider unaudited standalone and consolidated half-yearly financial results for September 2026. Trading window is closed from 01-Oct-2026.
Accedere Board Meeting Date
Accedere Limited intimated a board meeting on 4 November 2026 to consider its unaudited Q2 standalone and consolidated results. Trading window closure is also noted, so this is a future meeting notice.
Systematic Industries Board Meeting Date
Systematic Industries Limited intimates a board meeting on November 3, 2026, to consider unaudited standalone results for the half year ended September 30, 2026. The trading window is closed from October 1, 2026 until 48 hours after the results are declared.